The Human Papilloma Virus vaccine has been making the headlines in the recent months. Who make the ideal candidates for receiving this vaccine and what are its benefits?
State the recommended recipients of the HPV vaccine and its health benefits, with brief context on why it was in the news.
Common trap: Answer both parts: girls of about 9–13 before sexual debut, and benefits against cervical and other cancers; mention the controversy over the 2010 trials in Andhra Pradesh and Gujarat.
SyllabusOld-pattern GS Paper II (2006–12): Developments in Science and Technology — health and biotechnology
Model answer
5 marks · 50-word limitHPV vaccines, the quadrivalent Gardasil and the bivalent Cervarix, protect against HPV types 16 and 18, which cause about 70 per cent of cervical cancers. They made news after deaths during a PATH-run demonstration project in Andhra Pradesh and Gujarat led to its suspension in 2010 and to public-interest litigation.
Ideal candidates and benefits
- Candidates: Girls aged roughly 9 to 13 before sexual debut, when the immune response is strongest; catch-up doses for young women, and boys in some countries.
- Benefits: Prevents cervical cancer, a leading cause of cancer death among Indian women, as well as some anal and throat cancers; the quadrivalent vaccine also prevents genital warts.
Vaccination must be paired with informed consent, monitoring and screening.
Read more — sources
- ReportWorld Health Organization, Human papillomavirus vaccines: WHO position paper (Weekly Epidemiological Record, April 2009)
- OfficialIndian Council of Medical Research, statement on the suspension of the HPV vaccine demonstration project (April 2010)
More from GS Paper II (old) 2012
Model answer by the EdiShorts editorial team. It is one well-argued treatment of the question, written to the official word limit — not an official UPSC answer key.